Know Cancer

or
forgot password

Korean Hereditary Breast Cancer Study


N/A
20 Years
N/A
Open (Enrolling)
Both
Breast Cancer, Ovarian Cancer

Thank you

Trial Information

Korean Hereditary Breast Cancer Study


1. To find founder mutation in Korean

2. To correlation prevalence with risk evaluation

3. To find risk factors concerning life style


Inclusion Criteria:



- Over 19 years old

- Agree to this study

- Breast cancer patient with family history of breast/ovarian cancer (1 subgroup)

- Breast cancer patient; young age (<40), bilateral, male, combined ovarian (2
subgroup)

- Family members with 1, 2 subgroups (3 subgroup)

Exclusion Criteria:

- Under 20 years old

- Unable to decide for oneself

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Find out the prevalence of BRCA1/2 mutation of high risk breast cancer patients

Outcome Time Frame:

6 years

Safety Issue:

Yes

Principal Investigator

Sung-Won Kim, M.D, Ph.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

Department of Surgery, Breast & Endocrine Service, Seoul National University Bundang Hospital

Authority:

Korea: Food and Drug Administration

Study ID:

KBCSG003

NCT ID:

NCT00595348

Start Date:

November 2007

Completion Date:

May 2017

Related Keywords:

  • Breast Cancer
  • Ovarian Cancer
  • Breast Neoplasms
  • Ovarian Neoplasms

Name

Location